Table 2.

Baseline Immune Data

	Amalgam		Composite
Variable	N	Mean	N	Mean
Total WBC	31	11.6±3.3	30	1.8±4.4
% Lymphocytes	30	39.2±11.9	30	41±11.9
% Granulocyes	30	52.8±11.8	30	52.0±11.4
% Monocytes	30	6.6±1.7	30	6.0±1.7
T-cell function:
%CD69+ (control)	30	3.5±2.4	30	3.0±2.6
%CD69+ (PHA)	30	83.9±9.5	30	82.2±16.0
%CD25+ (control)	30	5.2±3.2	30	4.5±3.1
%CD25+ (PHA)	30	77.0±16.3	30	74.7±21.9
B-cell function:
%CD69+ (control)	30	13.6±7.6	30	15.4±8.6
%CD69+ (PWM)	30	75.6±13.9	30	71.5±14.9
%CD23+ (control)	30	10.3±7.7	30	11.6±8.3
%CD23+ (PHA)	30	47.5±18.3	30	39.3±20.7
Monocyte function:
% Eth+(control)	30	6.6±4.0	29	5.9±3.6
% Eth+(PMA)	30	69.7±15.8	29	65.6±19.8
% Rho+(control)	30	5.6±7.1	29	5.7±10.0
% Rho+(PMA)	30	55.7±21.5	29	54.2±22.4
Neutrophil function:
% Eth+(control)	30	5.2±3.4	30	4.6±2.8
% Eth+(PMA)	30	92.2±7.5	30	88.9±16.9
% Rho+(control)	30	5.9±15.2	30	2.8±2.5
% Rho+(PMA)	30	87.6±17.8	30	82.4±19.7